Flowchart displaying the steps of the present study. by Jingtian Yang (11966345)

Subjects:

Juvenile demyelination leads to a substantial decrease in potassium currents in PV interneurons of the PFC. by Sara Hijazi (21656615)

“…Scale: 500 pA, 100 ms. <b>B</b>. I–V curves showing a significant decrease in Kv amplitude in PV interneurons from mice that underwent juvenile demyelination. …”

Top 10 significantly changed metabolites and lipids in each clinical outcome measure group. by Patricia Sikorski (1320966)

“…The orange color indicates increase in levels and the blue color represent decrease in levels. (A) MMS status, yes vs. no (B) change in (Δ) QMG (> 40% vs. < 0%) (C) change in (Δ) MG-ADL (> 40% vs. < 0%), (D) Responder versus Non-Responder. …”

Comparison of diffusion simulations: implicit scheme of the GDE with a 30-second time step (blue line), implicit scheme of the PNGM with α = 0.6 and a 15-second time step (green li... by Mouad Klai (20818364)

Conditional <i>Aff4</i> knockout decreases fat mass in mice. by Yaqian Chen (1711576)

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA.... by Emir Matpan (21655811)

“…Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. …”

Seven out of the 11 human cytidine deaminases are more highly expressed in tumor versus normal tissue and their higher expression is correlated with a decrease in survival. by Mason A. McCool (11889842)

“…<p>(A) Higher expression of 8 out of the 11 human cytidine deaminases correlates with decreased survival probability. …”

Minimum number of patients to detect a significant protective effect of a drug against BRAO-induced GCL thickness loss. by Thomas R. Shearer (9761486)

Creep failure mode and sketch map of step-step fractured rock. by Dengke Yang (842532)

Bexarotene pretreatment significantly suppressed HBV and HDV infections in primary human hepatocytes (PHH). by Sameh A. Gad (12269979)

Data for subjects with significant slopes (regional progression or recovery colour coded, non-significant regions white) for the 4 data types over the study period. by Faran Sabeti (6166766)

Subjects:

How significant a role can China’s forest sector play in decarbonizing its economy? by Jianyun Hou (13018981)

<i>neurod1</i>^<i>ΔUCE</i> homozygous mutants display a decrease in the expression of several EE hormones. by Anne Sophie Reuter (12239993)

siRNA-based knockdown of <i>CLU</i> results in decreased VWF and CLU protein expression but no change in <i>VWF</i> mRNA content. by Allaura A. Cox (17980027)

Subjects:

Increase in physical activity (100 step, 500 steps or 1000 steps) after the challenge according to decrease in screen time < or ≥60 minutes. by Annaëlle Le Steunf (19838110)

Knock-down of <i>PYCR1</i> decreases proliferation of CRC cell lines. by Saif Sattar Alaqbi (12055053)

Bootstrapped spearman correlations from a randomly selected subset of male sample donor originating samples (n = 493). by Arttu Autio-Kimura (20454681)

Subjects:

Top significantly changed pathways based on their calculated enrichment factor and significance value. by Homica Arya (10954373)

“…<p>Top significantly changed pathways based on their calculated enrichment factor and significance value.…”

(A) Shape of the osteotomies during the 3-step MIPS drilling procedure. by Marsel Ganeyev (21453399)

Subjects:

<i>neurod1</i>^<i>ΔUCE</i> homozygous mutants display an increase of the goblet cells concomitant with a decrease of EECs. by Anne Sophie Reuter (12239993)